13177-70-3

Basic information

• Product Name: Furo[2,3-d]pyridazine, 4,7-dichloro
• Synonyms: Furo[2,3-d]pyridazine, 4,7-dichloro
• CAS NO: 13177-70-3
• Molecular Formula: C₆H₂Cl₂N₂O
• Molecular Weight: 188.99888
• Mol File: 13177-70-3.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Furo[2,3-d]pyridazine, 4,7-dichloro(CAS DataBase Reference)
• NIST Chemistry Reference: Furo[2,3-d]pyridazine, 4,7-dichloro(13177-70-3)
• EPA Substance Registry System: Furo[2,3-d]pyridazine, 4,7-dichloro(13177-70-3)

Safety Data

• Hazardous Substances Data: 13177-70-3(Hazardous Substances Data)

Usage

General Description

Furo[2,3-d]pyridazine, 4,7-dichloro is a chemical compound with the molecular formula C5H2Cl2N2O. It is a bicyclic heterocyclic compound that contains a furo[2,3-d]pyridazine core with two chlorine atoms attached at the 4 and 7 positions. Furo[2,3-d]pyridazine, 4,7-dichloro has potential application in the field of medicinal chemistry, specifically in the development of pharmaceutical drugs. It may also have uses in other areas such as industrial synthesis and research. The specific properties and potential uses of furo[2,3-d]pyridazine, 4,7-dichloro may vary depending on its specific chemical structure and the manner in which it is synthesized.

Upstream product

• 488-93-7 3-Furoic acid 
• 14757-85-8 7-chloro-5H-furo[2,3-d]pyridazin-4-one 
• 4282-24-0 furan-2,3-dicarboxylic acid 
• 37127-84-7 7-chloro-4-oxo-4,5-dihydrofuro[2,3-d]pyridazine-2-carboxylic acid 
• 13177-71-4 5,6-dihydrofuro[2,3-d]pyridazine-4,7-dione 
• 37441-69-3 4,7-dichlorofuro[2,3-d]pyridazine-2-carboxylic acid 
• 52900-79-5 methyl 3-methoxycarbonylfuran-2-carboxylate 
• 13379-61-8 furan-2,3-dicarboxylic acid dihydrazide 

Downstream Products

• 332012-57-4 4-[({4-[(3-chlorophenyl)amino]-furo[2,3-d]pyridazin-7-yl}oxy)methyl]-N-methyl-2-pyridinecarboxamide 
• 332012-40-5 Telatinib 
• 332012-41-6 4-(4-chlorophenylamino)-2-methylaminocarbonyl-7-(2-methylaminocarbonyl-4-pyridylmethoxy)-furo[2,3-d]pyridazine 
• 332012-46-1 4-[({4-[(4-methoxyphenyl)amino]furo[2,3-d]pyridazin-7-yl}oxy)methyl]-N-methyl-2-pyridinecarboxamide 
• 1057681-50-1 7-benzyl-4-[4-(5-trifluoromethylpyridin-2-yl)piperazin-1-yl]furo[2,3-d]pyridazine 
• 332013-41-9 4-chloro-7-[N-(4-chlorophenyl)amino]-[2,3-d]furopyridazine 
• 1057681-53-4 4-benzyl-7-[4-(5-trifluoromethylpyridin-2-yl)piperazin-1-yl]furo[2,3-d]pyridazine 
• 332013-51-1 4-(4-methoxyphenylamino)-7-chlorofuro-[2,3-d]pyridazine 
• 332013-40-8 4-chloroanilino-7-chlorofuro[2,3-d]pyridazine 
• 271-93-2 Furo<2,3-d>pyridazin 

Relevant articles and documents

SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY

Substituted pyridines and pyridazines having angiogenesis inhibiting activity and generalized structural formula (I) wherein the ring containing A, B, D, E, and L is phenyl or a nitrogen-containing heterocycle; groups X and Y may be any of a variety of defined linking units; R and R may be defined independent substituents or together may be a ring-defining bridge; ring J may be an aryl, pyridyl, or cycloalkyl group; and G groups may be any of a variety of defined substituents. Pharmaceutical compositions containing these materials, and methods of treating a mammal having a condition characterized by abnormal angiogenesis or hyperpermeability processes using these materials are also disclosed.

COMPOUNDS FOR TREATING PULMONARY HYPERTENSION

The present invention relates to pharmaceutical compositions and combinations for treating, preventing or managing pulmonary hypertension comprising small molecule heterocyclic pharmaceuticals, and more particularly, substituted pyridines and pyridazines optionally combined with at least one additional therapeutic agent.